Cargando…

Correction: Aptamer: A potential oligonucleotide nanomedicine in the diagnosis and treatment of hepatocellular carcinoma

Detalles Bibliográficos
Autores principales:	Ladju, Rusdina Bte, Pascut, Devis, Massi, Muhammad Nasrum, Tiribelli, Claudio, Sukowati, Caecilia H.C.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Impact Journals LLC 2018
Materias:	Correction
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5849200/ https://www.ncbi.nlm.nih.gov/pubmed/29569656 http://dx.doi.org/10.18632/oncotarget.24572

Ejemplares similares

Aptamer: A potential oligonucleotide nanomedicine in the diagnosis and treatment of hepatocellular carcinoma
por: Ladju, Rusdina Bte, et al.
Publicado: (2017)

Serum Stem Cell Growth Factor Beta for the Prediction of Therapy Response in Hepatocellular Carcinoma
por: Sukowati, Caecilia H. C., et al.
Publicado: (2018)

Circulating Long and Circular Noncoding RNA as Non-Invasive Diagnostic Tools of Hepatocellular Carcinoma
por: Sukowati, Caecilia H. C., et al.
Publicado: (2021)

Gene and functional up-regulation of the BCRP/ABCG2 transporter in hepatocellular carcinoma
por: Sukowati, Caecilia HC, et al.
Publicado: (2012)

Nanotheranostics: A powerful next-generation solution to tackle hepatocellular carcinoma
por: Ladju, Rusdina Bte, et al.
Publicado: (2022)

Expression of miRNA-29a-3p and IFN-γ as biomarkers in active and latent pulmonary tuberculosis
por: Angria, Nirmawati, et al.
Publicado: (2022)

Serum AP-endonuclease 1 (sAPE1) as novel biomarker for hepatocellular carcinoma
por: Pascut, Devis, et al.
Publicado: (2019)

Sorafenib Resistance in Hepatocellular Carcinoma: The Relevance of Genetic Heterogeneity
por: Cabral, Loraine Kay D., et al.
Publicado: (2020)

Immunotherapy against programmed death-1/programmed death ligand 1 in hepatocellular carcinoma: Importance of molecular variations, cellular heterogeneity, and cancer stem cells
por: Sukowati, Caecilia H C, et al.
Publicado: (2021)

Circulatory miRNA as a Biomarker for Therapy Response and Disease-Free Survival in Hepatocellular Carcinoma
por: Pratama, Muhammad Yogi, et al.
Publicado: (2020)

HCC occurrence after DAA treatments: molecular tools to assess the post-treatment risk and surveillance
por: Pascut, Devis, et al.
Publicado: (2020)

Selection and validation of miR-1280 as a suitable endogenous normalizer for qRT-PCR Analysis of serum microRNA expression in Hepatocellular Carcinoma
por: Pratama, Muhammad Yogi, et al.
Publicado: (2020)

The Crosstalk between Tumor Cells and the Microenvironment in Hepatocellular Carcinoma: The Role of Exosomal microRNAs and Their Clinical Implications
por: Pascut, Devis, et al.
Publicado: (2020)

Biomarkers for the Detection and Management of Hepatocellular Carcinoma in Patients Treated with Direct-Acting Antivirals
por: Cabral, Loraine Kay D., et al.
Publicado: (2022)

HCV Proteins Modulate the Host Cell miRNA Expression Contributing to Hepatitis C Pathogenesis and Hepatocellular Carcinoma Development
por: Pascut, Devis, et al.
Publicado: (2021)

Silencing efficacy prediction: a retrospective study on target mRNA features
por: Pascut, Devis, et al.
Publicado: (2015)

Role of hepatitis B virus in development of hepatocellular carcinoma: Focus on covalently closed circular DNA
por: Bianca, Claryssa, et al.
Publicado: (2022)

Weighted miRNA co-expression networks analysis identifies circulating miRNA predicting overall survival in hepatocellular carcinoma patients
por: Pascut, Devis, et al.
Publicado: (2020)

The Expression of CD90/Thy-1 in Hepatocellular Carcinoma: An In Vivo and In Vitro Study
por: Sukowati, Caecilia Hapsari Ceriapuri, et al.
Publicado: (2013)

The Relevance of SOCS1 Methylation and Epigenetic Therapy in Diverse Cell Populations of Hepatocellular Carcinoma
por: Cabral, Loraine Kay D., et al.
Publicado: (2021)

PD-L1 Downregulation and DNA Methylation Inhibition for Molecular Therapy against Cancer Stem Cells in Hepatocellular Carcinoma
por: Sukowati, Caecilia, et al.
Publicado: (2023)

The Role of microRNAs in the Cisplatin- and Radio-Resistance of Cervical Cancer
por: Masadah, Rina, et al.
Publicado: (2021)

The role of multipotent cancer associated fibroblasts in hepatocarcinogenesis
por: Sukowati, Caecilia Hapsari Ceriapuri, et al.
Publicado: (2015)

Serum miRNA Are Promising Biomarkers for the Detection of Early Hepatocellular Carcinoma after Treatment with Direct-Acting Antivirals
por: Pascut, Devis, et al.
Publicado: (2019)

MiR-3201 as a Prognostic Blood Biomarker for Curative Treatments in Hepatocellular Carcinoma
por: Grisetti, Luca, et al.
Publicado: (2022)

The Expression Level of ABCC6 Transporter in Colon Cancer Cells Correlates with the Activation of Different Intracellular Signaling Pathways
por: Abruzzese, Vittorio, et al.
Publicado: (2022)

Correction to: Nanomedicine‐boosting icaritin-based immunotherapy of advanced hepatocellular carcinoma
por: Lu, Yi, et al.
Publicado: (2023)

Circulating microRNA Associated to Different Stages of Liver Steatosis in Prader–Willi Syndrome and Non-Syndromic Obesity
por: Pratama, Muhammad Yogi, et al.
Publicado: (2020)

Repeated double cross-validation applied to the PCA-LDA classification of SERS spectra: a case study with serum samples from hepatocellular carcinoma patients
por: Gurian, Elisa, et al.
Publicado: (2020)

Aptamers and Antisense Oligonucleotides for Diagnosis and Treatment of Hematological Diseases
por: Giudice, Valentina, et al.
Publicado: (2020)

Clinical Significance of Apurinic/Apyrimidinic Endodeoxyribonuclease 1 and MicroRNA Axis in Hepatocellular Carcinoma
por: Mangiapane, Giovanna, et al.
Publicado: (2023)

A comparative characterization of the circulating miRNome in whole blood and serum of HCC patients
por: Pascut, Devis, et al.
Publicado: (2019)

Network Analysis for the Discovery of Common Oncogenic Biomarkers in Liver Cancer Experimental Models
por: Cabral, Loraine Kay D., et al.
Publicado: (2023)

Bilirubin-Induced Transcriptomic Imprinting in Neonatal Hyperbilirubinemia
por: Llido, John Paul, et al.
Publicado: (2023)

Activation of hepatic stem cells compartment during hepatocarcinogenesis in a HBsAg HBV-transgenic mouse model
por: Anfuso, Beatrice, et al.
Publicado: (2018)

Hyaluronic acid inhibition by 4-methylumbelliferone reduces the expression of cancer stem cells markers during hepatocarcinogenesis
por: Sukowati, Caecilia H. C., et al.
Publicado: (2019)

Advances in Oligonucleotide Aptamers for NSCLC Targeting
por: Rotoli, Deborah, et al.
Publicado: (2020)

Differences in circulating microRNA signature in Prader–Willi syndrome and non-syndromic obesity
por: Pascut, Devis, et al.
Publicado: (2018)

Aptamer-Equipped Protamine Nanomedicine for Precision Lymphoma Therapy
por: Zeng, Zihua, et al.
Publicado: (2020)

Correction: A Tandem Oligonucleotide Approach for SNP-Selective RNA Degradation Using Modified Antisense Oligonucleotides
por: Magner, Dorota, et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_avsblfoc5nn4ug76ju5788dnea